Literature DB >> 6650504

The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.

G M Petersen, J I Rotter, R M Cantor, L L Field, S Greenwald, J S Lim, C Roy, V Schoenfeld, J A Lowden, M M Kaback.   

Abstract

From data collected in a North American Tay-Sachs disease (TSD) heterozygote screening program, the TSD carrier frequency among 46,304 Jewish individuals was found to be .0324 (1 in 31 individuals). This frequency is consistent with earlier estimates based on TSD incidence data. TSD carrier frequencies were then examined by single country and single region of origin in 28,029 Jews within this sample for whom such data were available for analysis. Jews with Polish and/or Russian ancestry constituted 88% of this sample and had a TSD carrier frequency of .0327. No TSD carriers were observed among the 166 Jews of Near Eastern origins. Relative to Jews of Polish and Russian origins, there was at least a twofold increase in the TSD carrier frequency in Jews of Austrian, Hungarian, and Czechoslovakian origins (P less than .005). These findings suggest that the TSD gene proliferated among the antecedents of modern Ashkenazi Jewry after the Second Diaspora (70 A.D.) and before their major migrations to regions of Poland and Russia (before 1100 A.D.).

Entities:  

Mesh:

Year:  1983        PMID: 6650504      PMCID: PMC1685967     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Tay-Sachs disease: genetic drift among the Ashkenazim Jews.

Authors:  A L Fraikor
Journal:  Soc Biol       Date:  1977

2.  Tay-Sachs disease: a genetic-historical view of selective advantage.

Authors:  N C Myrianthopoulos; M Melnick
Journal:  Prog Clin Biol Res       Date:  1977

3.  Automated assay of hexosaminidases in serum.

Authors:  J A Lowden; M A Skomorowski; F Henderson; M Kaback
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

4.  Founder effect in Tay-Sachs disease unlikely.

Authors:  N C Myrianthopoulos; A F Naylor; S M Aronson
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

5.  Controversy in human genetics: founder effect in Tay-Sachs disease.

Authors:  G A Chase; V A McKusick
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

6.  On the maintenance of polymorphisms having an inviable homozygote.

Authors:  O Mayo
Journal:  Ann Hum Genet       Date:  1970-01       Impact factor: 1.670

Review 7.  Approaches to the control and prevention of Tay-Sachs disease.

Authors:  M M Kaback; R S Zeiger; L W Reynolds; M Sonneborn
Journal:  Prog Med Genet       Date:  1974

8.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay.

Authors:  J S O'Brien; S Okada; A Chen; D L Fillerup
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

9.  Population dynamics of Tay-Sachs disease. I. Reproductive fitness and selection.

Authors:  N C Myrianthopoulos; S M Aronson
Journal:  Am J Hum Genet       Date:  1966-07       Impact factor: 11.025

10.  Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1969-08-15       Impact factor: 47.728

View more
  25 in total

1.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

2.  Firing up the nature/nurture controversy: bioethics and genetic determinism.

Authors:  I de Melo-Martín
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

3.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

Review 4.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

6.  Primer system for single cell detection of double mutation for Tay-Sachs disease.

Authors:  M C Liu; K C Drury; S Kipersztok; W Zheng; R S Williams
Journal:  J Assist Reprod Genet       Date:  2000-02       Impact factor: 3.412

7.  Gene encoding the human beta-hexosaminidase beta chain: extensive homology of intron placement in the alpha- and beta-chain genes.

Authors:  R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.

Authors:  B L Triggs-Raine; E H Mules; M M Kaback; J S Lim-Steele; C E Dowling; B R Akerman; M R Natowicz; E E Grebner; R Navon; J P Welch
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

9.  A retrospective survey of community based utilization of Tay Sachs screening in Eight New Jersey counties.

Authors:  R Wallerstein; K Seshadri; S Brady-Yasbin; L Y Shih; D F Wallerstein
Journal:  J Genet Couns       Date:  1994-06       Impact factor: 2.537

10.  Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.

Authors:  B Triggs-Raine; M Richard; N Wasel; E M Prence; M R Natowicz
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.